Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Folic acid 2mg/5ml oral liquid
0901020G0AACBCB
|
Folic acid | Folic acid | Nutrition and Blood | No data available |
|
Folic acid 300micrograms/5ml oral liquid
0901020G0AACFCF
|
Folic acid | Folic acid | Nutrition and Blood | No data available |
|
Folic acid 400micrograms/5ml oral liquid
0901020G0AACACA
|
Folic acid | Folic acid | Nutrition and Blood | No data available |
|
Folic acid 4mg/5ml oral liquid
0901020G0AACWCW
|
Folic acid | Folic acid | Nutrition and Blood | No data available |
|
Folic acid 500micrograms/5ml oral liquid
0901020G0AABWBW
|
Folic acid | Folic acid | Nutrition and Blood | No data available |
|
Folic acid 750micrograms/5ml oral liquid
0901020G0AACKCK
|
Folic acid | Folic acid | Nutrition and Blood | No data available |
|
Folicare 400micrograms/5ml oral solution
0901020G0CIAACN
|
Folicare | Folic acid | Nutrition and Blood | No data available |
|
Follitropin alfa 1,050unit inj vials
0605010I0AAAFAF
|
Follitropin alfa | Follitropin alfa | Endocrine System | No data available |
|
Follitropin alfa 150unit / Lutropin alfa 75unit inj vials
0605010ABAAAAAA
|
Follitropin alfa and lutropin alfa | Follitropin alfa and lutropin alfa | Endocrine System | No data available |
|
Follitropin alfa 150unit inj ampoules
0605010I0AAABAB
|
Follitropin alfa | Follitropin alfa | Endocrine System | No data available |
|
Follitropin alfa 150units/0.25ml inj pf disposable devices
0605010I0AAALAL
|
Follitropin alfa | Follitropin alfa | Endocrine System | No data available |
|
Follitropin alfa 225units/0.375ml inj pf disposable devices
0605010I0AAAMAM
|
Follitropin alfa | Follitropin alfa | Endocrine System | No data available |
|
Follitropin alfa 300units/0.48ml inj pf disposable devices
0605010I0AAAUAU
|
Follitropin alfa | Follitropin alfa | Endocrine System | No data available |
|
Follitropin alfa 300units/0.5ml inj cartridges
0605010I0AAARAR
|
Follitropin alfa | Follitropin alfa | Endocrine System | No data available |
|
Follitropin alfa 300units/0.5ml inj pf disposable devices
0605010I0AAANAN
|
Follitropin alfa | Follitropin alfa | Endocrine System | No data available |
|
Follitropin alfa 300units/0.5ml inj pre-filled syringes
0605010I0AAAHAH
|
Follitropin alfa | Follitropin alfa | Endocrine System | No data available |
|
Follitropin alfa 37.5unit inj ampoules
0605010I0AAACAC
|
Follitropin alfa | Follitropin alfa | Endocrine System | No data available |
|
Follitropin alfa 450unit inj vials
0605010I0AAAGAG
|
Follitropin alfa | Follitropin alfa | Endocrine System | No data available |
|
Follitropin alfa 450units/0.72ml inj pf disposable devices
0605010I0AAAVAV
|
Follitropin alfa | Follitropin alfa | Endocrine System | No data available |
|
Follitropin alfa 450units/0.75ml inj cartridges
0605010I0AAASAS
|
Follitropin alfa | Follitropin alfa | Endocrine System | No data available |
|
Follitropin alfa 450units/0.75ml inj pf disposable devices
0605010I0AAAPAP
|
Follitropin alfa | Follitropin alfa | Endocrine System | No data available |
|
Follitropin alfa 450units/0.75ml inj pre-filled syringes
0605010I0AAAIAI
|
Follitropin alfa | Follitropin alfa | Endocrine System | No data available |
|
Follitropin alfa 450units/Lutropin alfa 225units/0.72ml inj
0605010ABAAABAB
|
Follitropin alfa and lutropin alfa | Follitropin alfa and lutropin alfa | Endocrine System | No data available |
|
Follitropin alfa 75unit inj ampoules
0605010I0AAAAAA
|
Follitropin alfa | Follitropin alfa | Endocrine System | No data available |
|
Follitropin alfa 75unit inj vials
0605010I0AAAEAE
|
Follitropin alfa | Follitropin alfa | Endocrine System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.